HOX Therapeutics Ltd
www.hoxtherapeutics.comHOX Therapeutics is developing new treatments for prostate cancer including a new class of drugs based on the inhibition of HOX transcription factors, development genes which are overexpressed in cancer. In a parallel programme HOX is working on novel inhibitors of the androgen receptors in those patients insensitive to current drugs for castration resistant prostate cancer.
Read more
HOX Therapeutics is developing new treatments for prostate cancer including a new class of drugs based on the inhibition of HOX transcription factors, development genes which are overexpressed in cancer. In a parallel programme HOX is working on novel inhibitors of the androgen receptors in those patients insensitive to current drugs for castration resistant prostate cancer.
Read more
Employees statistics
View all employeesPotential Decision Makers
Chief Executive Officer
Email ****** @****.comPhone (***) ****-****Non Executive Director
Email ****** @****.comPhone (***) ****-****Financial Controller
Email ****** @****.comPhone (***) ****-****
